{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:17:08Z","timestamp":1777897028860,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.phymed.2008.04.004","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T13:50:00Z","timestamp":1210254600000},"page":"391-399","source":"Crossref","is-referenced-by-count":75,"title":["Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study"],"prefix":"10.1016","volume":"15","author":[{"given":"Limas","family":"Kupcinskas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lafolie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5ke","family":"Lignell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gediminas","family":"Kiudelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laimas","family":"Jonaitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kestutis","family":"Adamonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif Percival","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torkel","family":"Wadstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2008.04.004_bib1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/bmj.315.7118.1284","article-title":"Dyspepsia management in general practise","volume":"315","author":"Agr\u00e9us","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2008.04.004_bib2","series-title":"Helicobacter pylori: Basic Mechanisms to Clinical Cure","first-page":"407","article-title":"Acute infection with Helicobacter pylori","author":"Axon","year":"1994"},{"key":"10.1016\/j.phymed.2008.04.004_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00365549309008483","article-title":"Helicobacter pylori in 205 consecutive endoscopy patients","volume":"25","author":"Befrits","year":"1993","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.phymed.2008.04.004_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-2478(99)00145-5","article-title":"Treatment of Helicobacter pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load, and modulates cytokine release by splenocytes","volume":"70","author":"Bennedsen","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.phymed.2008.04.004_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00042737-199805000-00004","article-title":"A community based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology","volume":"10","author":"Buckley","year":"1998","journal-title":"Eur. J. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phymed.2008.04.004_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2036.1997.117288000.x","article-title":"Cisapride in functional dyspepsia in general practice: a placebo-controlled, randomized, double blind study","volume":"11","author":"de Grot GadB","year":"1997","journal-title":"Aliment Pharmacol. Ther."},{"issue":"Suppl. (221)","key":"10.1016\/j.phymed.2008.04.004_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/00365529609095544","article-title":"Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease","volume":"31","author":"Dimen\u00e4s","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib10","first-page":"132","article-title":"Prevalence of Helicobacter pylori infection in the Czech Republic\u2014the south Moravia region","volume":"44","author":"Dite","year":"1998","journal-title":"Vnitmi. Lakertstvi."},{"key":"10.1016\/j.phymed.2008.04.004_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004836-198904000-00011","article-title":"Drug treatment of functional dyspepsia: a meta-analysis of randomised controlled trials","volume":"11","author":"Dobrila","year":"1989","journal-title":"J. Clin. Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.phymed.2008.04.004_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2036.1999.00003.x","article-title":"The role of inflammation in the pathogenesis of gastric cancer","volume":"13","author":"Ernst","year":"1999","journal-title":"Alim. Pharmacol. Therapeut."},{"key":"10.1016\/j.phymed.2008.04.004_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004836-199806000-00022","article-title":"Meta-analysis of antisecretory and gastrokinetic compounds in fucntional dyspepsia","volume":"26","author":"Finney","year":"1998","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00001574-199911000-00006","article-title":"Non-ulcer dyspepsia","volume":"15","author":"Hammer","year":"1999","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/np050354+","article-title":"Astaxanthin, a carotenoid with potential in human health and nutrition","volume":"69","author":"Hussein","year":"2006","journal-title":"J. Nat. Prod."},{"issue":"Suppl. 583","key":"10.1016\/j.phymed.2008.04.004_bib16","first-page":"106","article-title":"Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia","volume":"164","author":"Junghard","year":"1998","journal-title":"Eur. J. Surg."},{"key":"10.1016\/j.phymed.2008.04.004_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365528909093029","article-title":"Endoscopic findings and diagnosis in unselected dyspeptic patients at a primary health care center","volume":"24","author":"Kagevi","year":"1989","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2005.03.034","article-title":"Protective effect of astaxanthin on naproxen-induced gastric antral ulceration in rats","volume":"514","author":"Kim","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2008.04.004_bib19","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1271\/bbb.69.1300","article-title":"Suppressive effect of astaxanthin isolated from the Xanthophyllomyces dendrorhous mutant on ethanol-induced gastric mucosal injury in rats","volume":"69","author":"Kim","year":"2005","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"Suppl. III","key":"10.1016\/j.phymed.2008.04.004_bib20","first-page":"A189","article-title":"Symptomatic pattern of HP negative and positive functional dyspepsia (FD) in the high HP prevalence area","volume":"51","author":"Kiudelis","year":"2002","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.phymed.2008.04.004_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1523-5378.2005.00340.x","article-title":"Helicobacter pylori and non-malignant diseases","volume":"10","author":"Kupcinskas","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.phymed.2008.04.004_bib23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/BF02087905","article-title":"Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study","volume":"41","author":"Lazzaroni","year":"1996","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phymed.2008.04.004_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1016-8478(23)13772-1","article-title":"Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I\u03baB kinase-dependent NF-\u03baB activation","volume":"1","author":"Lee","year":"2003","journal-title":"Mol. Cells"},{"key":"10.1016\/j.phymed.2008.04.004_bib25","unstructured":"Lignell, A., Surace, R., Bottiger, P., Borody, T.J., 1999. Symptom improvement in Helicobacter pylori positive non-ulcer dyspeptic patient after treatment with the carotenoid astaxanthin. In: International Carotenoid Symposium, Cairns, Australia, 18\u201323 July 1999."},{"key":"10.1016\/j.phymed.2008.04.004_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1440-1746.1998.tb00677.x","article-title":"Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne","volume":"13","author":"Lin","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2008.04.004_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000076546","article-title":"Treatment of functional Dyspepsia with a herbal preparation","volume":"69","author":"Madish","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.phymed.2008.04.004_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Alim. Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2008.04.004_bib29","first-page":"59","article-title":"Guidelines for the management of Helicobacter pylori infection. Summary of the Maastricht-3 Consensus Report (Business briefing)","author":"Malfertheiner","year":"2005","journal-title":"Eur. Gastroenterol. Rev."},{"key":"10.1016\/j.phymed.2008.04.004_bib30","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","article-title":"Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia","volume":"339","author":"McColl","year":"1998","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.phymed.2008.04.004_bib31","first-page":"115","article-title":"Serum ferritin, hemoglobin and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults","author":"Milman","year":"1998","journal-title":"Gastroenterol. Int."},{"issue":"1","key":"10.1016\/j.phymed.2008.04.004_bib32","first-page":"CD002096","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","author":"Moayyedi","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phymed.2008.04.004_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.gassur.2005.09.003","article-title":"Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1 and cyclooxygenase-2 in esophageal epithelial cells","volume":"10","author":"Mohamed","year":"2006","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.phymed.2008.04.004_bib34","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.4049\/jimmunol.156.12.4729","article-title":"Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomach of mice","volume":"156","author":"Mohammadi","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2008.04.004_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0891-5849(02)00868-7","article-title":"Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress","volume":"33","author":"Naito","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phymed.2008.04.004_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3177\/jnsv.51.135","article-title":"Effects of astaxanthin and vitamin C on the prevention of gastric ulcerations in stressed rats","volume":"51","author":"Nishikawa","year":"2005","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.phymed.2008.04.004_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.49.3.364","article-title":"Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats","volume":"49","author":"Oh","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2008.04.004_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1474-8673.2002.00241.x","article-title":"Effects of rutin and harmaline on rat reflux oesophagitis","volume":"22","author":"Shin","year":"2002","journal-title":"Autonom. Utacoid Pharmacol."},{"key":"10.1016\/j.phymed.2008.04.004_bib39","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/00365528909093113","article-title":"Controled clinical trial with sucralfate in the treatment of macroscopic gastritis","volume":"24","author":"Skuobo-Kristensen","year":"1989","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/gut.34.8.1038","article-title":"Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations","volume":"34","author":"Sobala","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2008.04.004_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00042737-199804000-00005","article-title":"Lack of correlation between self-reported symptoms of dyspepsia and infection with Helicobaxter pylori in a general population sample","volume":"13","author":"Stone","year":"1998","journal-title":"Eur. J. Gastroenterol."},{"key":"10.1016\/j.phymed.2008.04.004_bib44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (The Bond and Opera studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Alim. Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2008.04.004_bib43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","article-title":"On behalf of the Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. Eradication of Helicobacter pylori in functional dyspepsia: a randomised double blind placebo controlled trial with 12 months\u2019 follow-up","volume":"318","author":"Talley","year":"1999","journal-title":"BMJ"},{"issue":"Suppl. 2","key":"10.1016\/j.phymed.2008.04.004_bib46","first-page":"II437","article-title":"Functional gastroduodenal disorders","volume":"45","author":"Talley","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2008.04.004_bib45","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1046\/j.1365-2036.2001.01074.x","article-title":"Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug in the treatment of functional dyspepsia with or without Helicobacter pylori infection","volume":"15","author":"Talley","year":"2001","journal-title":"Alim. Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2008.04.004_bib48","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1128\/AAC.44.9.2452-2457.2000","article-title":"Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter infection in BALB\/cA mice","volume":"44","author":"Wang","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2008.04.004_bib49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0002-9610(99)80014-2","article-title":"Reflux esophagitis in humans is mediated by oxygen-derived free radicals","volume":"170","author":"Wetscher","year":"1995","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.phymed.2008.04.004_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1440-1746.1997.tb00338.x","article-title":"Effect of cisapride on functional dyspepsia with and without gastritis: a double-blind placebo-controlled trial","volume":"12","author":"Yeoh","year":"1997","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711308000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711308000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:55:44Z","timestamp":1708908944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711308000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":46,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0944711308000767"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2008.04.004","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}